Vigonvita Life Sciences Co., Ltd. (HKG:2630)

Vigonvita Life Sciences Statistics

Total Valuation

HKG:2630 has a market cap or net worth of HKD 11.74 billion. The enterprise value is 11.87 billion.

Market Cap	11.74B
Enterprise Value	11.87B

Important Dates

The last earnings date was Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2630 has 167.60 million shares outstanding.

Current Share Class	66.68M
Shares Outstanding	167.60M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	63.04%
Owned by Institutions (%)	3.22%
Float	39.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	103.33
PB Ratio	24.21
P/TBV Ratio	27.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-29.99
EV / Sales	104.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-41.57

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 1.48.

Current Ratio	1.07
Quick Ratio	1.05
Debt / Equity	1.48
Debt / EBITDA	n/a
Debt / FCF	-2.52
Interest Coverage	-25.02

Financial Efficiency

Return on equity (ROE) is -123.98% and return on invested capital (ROIC) is -25.32%.

Return on Equity (ROE)	-123.98%
Return on Assets (ROA)	-20.73%
Return on Invested Capital (ROIC)	-25.32%
Return on Capital Employed (ROCE)	-43.69%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	315
Asset Turnover	0.10
Inventory Turnover	2.60

Taxes

In the past 12 months, HKG:2630 has paid 229,239 in taxes.

Income Tax	229,239
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	85.45
200-Day Moving Average	n/a
Relative Strength Index (RSI)	32.28
Average Volume (20 Days)	62,430

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2630 had revenue of HKD 113.61 million and -395.85 million in losses. Loss per share was -2.59.

Revenue	113.61M
Gross Profit	89.78M
Operating Income	-371.99M
Pretax Income	-397.17M
Net Income	-395.85M
EBITDA	-345.27M
EBIT	-371.99M
Loss Per Share	-2.59

Balance Sheet

The company has 576.09 million in cash and 719.51 million in debt, with a net cash position of -143.42 million or -0.86 per share.

Cash & Cash Equivalents	576.09M
Total Debt	719.51M
Net Cash	-143.42M
Net Cash Per Share	-0.86
Equity (Book Value)	484.85M
Book Value Per Share	2.96
Working Capital	41.26M

Cash Flow

In the last 12 months, operating cash flow was -107.58 million and capital expenditures -178.02 million, giving a free cash flow of -285.60 million.

Operating Cash Flow	-107.58M
Capital Expenditures	-178.02M
Depreciation & Amortization	27.81M
Net Borrowing	242.69M
Free Cash Flow	-285.60M
FCF Per Share	-1.70

Margins

Gross Margin	79.02%
Operating Margin	-327.41%
Pretax Margin	-349.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2630 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.37%
FCF Yield	-2.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2630 has an Altman Z-Score of 6.35 and a Piotroski F-Score of 1.

Altman Z-Score	6.35
Piotroski F-Score	1